Orca Bio

Director, Scientific Communications

Menlo Park, California, United States

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, HealthcareIndustries

Requirements

Candidates must possess an advanced clinical or scientific degree, with a Pharm.D. or Ph.D. preferred. A minimum of 8 years of experience in Medical Affairs or the pharmaceutical industry is required, along with over 5 years in medical/scientific communications or publications. Experience in the Hematology/Oncology therapeutic area, particularly cell therapy, is necessary, as is experience with promotional and medical review committees. Proficiency in relevant technology platforms like Medical Information database systems, SharePoint, Veeva, and PowerPoint is essential, along with a strong understanding of legal and regulatory guidelines in the pharmaceutical industry.

Responsibilities

The Director of Scientific Communications will establish and lead the Scientific Communications capability within Medical Affairs, developing an annual strategic plan for scientific communications and training. This role involves creating scientific tools and materials for Orca Bio's pipeline products, overseeing the publications function, and building a team. Responsibilities also include managing the continuing medical education grant program, supporting the training of Medical Affairs employees (especially the MSL team), contributing to clinical content for advisory boards and investigator meetings, and coordinating company-sponsored symposia. The Director will lead the development of a compendia and treatment guideline plan, create congress materials, manage platform for MSL resources, and oversee the Medical/Scientific Communication and Publications budget, including direct management of vendors.

Skills

Scientific Communications
MSL Materials
Medical Affairs
Publications
Continuing Medical Education
Biotechnology
Cell Therapies
Strategic Planning
Training

Orca Bio

Develops and commercializes cell therapies

About Orca Bio

Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently have limited treatment options.

Menlo Park, CaliforniaHeadquarters
2016Year Founded
$186.8MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Unlimited Paid Time Off
401(k) Retirement Plan
Parental Leave

Risks

Emerging competition from BlueRock Therapeutics in stem cell therapies.
Aspen Neuroscience's advancements in personalized stem cell therapies pose a threat.
Competitors' focus on iPSC-derived therapies may overshadow Orca Bio's offerings.

Differentiation

Orca Bio focuses on high-precision cell therapies for cancer and autoimmune diseases.
Their lead product, Orca-T, shows promising relapse-free survival rates in clinical trials.
Orca Bio's therapies aim to replace diseased blood and immune systems with healthy ones.

Upsides

Orca-T demonstrated 87% relapse-free survival in a Phase 1b/2 trial.
FDA's expedited approval pathways could accelerate Orca Bio's market entry.
Advancements in gene editing enhance the efficacy of Orca Bio's cell therapies.

Land your dream remote job 3x faster with AI